Entry Detail



General Information

Database ID:exR0460372
RNA Name:ZMAT2
RNA Type:mRNA
Chromosome:chr5
Starnd:+
Coordinate:
Start Site(bp):140698680End Site(bp):140706686
External Links:ENSG00000146007



Disease Information

Disease Name:
Disease Category:
MeSH ID:
Type:
Alias:



Expression Detail

GEO ID:GSE122377
Description:Tuberculous Meningitis in Pediatric Patients [CSF]
Experimental Design:Disease Sample Source
Case Disease Type:Pediatric TB meningitis
Case Disease SubType:NA
Case Sample:Ventricular Cerebrospinal Fluid
Control Sample:Lumbar Puncture Cerebrospinal Fluid
Number of Case:12
Number of Control:12
Number of Samples:24





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCC1
chr16
15949577
16143074
+
ACSL4
chrX
109624244
109733403
-
ACTA1
chr1
229431245
229434098
-
AD000671.2
chr19
35739252
35745432
-
AEN
chr15
88621337
88632281
+
AGRN
chr1
1020120
1056118
+
AHCY
chr20
34280268
34311802
-
AKR1A1
chr1
45550543
45570049
+
AL928654.3
chr14
105487199
105492267
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-362-3p
chrX
50009005
50009026
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016747.4
chr2
61115787
61164825
+
AC016876.2
chr17
7581964
7584086
-
AC099524.1
chr16
81738248
81767868
+
AC106881.1
chr4
95549129
95552457
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:31434901
Title:Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity
Author:Rohlwink UK, Figaji A, Wilkinson KA, Horswell S, Sesay AK, Deffur A, Enslin N, Solomons R, Van Toorn R, Eley B, Levin M, Wilkinson RJ, Lai RPJ
Journal:Nat Commun. 2019 Aug 21;10(1):3767.
Description:Differential transcript expression of TBM cases are compared with healthy controls in whole blood and with non-TB cerebral infection controls in CSF.